SCO-267
SCO-267 is an allosteric GPR40 full agonist. SCO-267 can be used for the research of chronic diseases including diabetes[1].
Product Specifications
CAS Number
[1656261-09-4]
UNSPSC
12352005
Target
Free Fatty Acid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/sco-267.html
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C)(C)CN(C1=CC=CC(C)=N1)C(C2=C(N3CCC(CC3)COC4=CC([C@H](C5CC5)CC(O)=O)=CC=N4)C=C(C=C2)OC)=O
Molecular Formula
C36H46N4O5
Molecular Weight
614.77
References & Citations
[1]Koyama R, et al. Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in Rats. Mol Pharmacol. 2021 Apr;99 (4) :286-293.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K5030806 1.0 µg DNA
Fas sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details VAng-2600Lsx-100g 100 µg
Mouse Neuroligin 1 Protein (Phe 22-Pro 856) [Fc]
Sign In for Pricing
View Details 